After the coronavirus vaccine was announced earlier this week the markets responded emphatically and, here, Laith Khalaf looks at what it all means for advisers and client portfolios...
A coronavirus vaccine doesn't change everything, but it changes a heck of a lot. We've already seen as much in the market's response to the news that Pfizer has an effective immunisation - yet to be peer reviewed and safety checked, but a hugely encouraging result nonetheless. Stock markets across the globe shot up as investors started to look forward to next year with something resembling hope. But not all share prices reacted to Pfizer's announcement positively. Indeed stock performance in the initial flurry of excitement might hint at a longer term trend if the vaccine is ultimately r...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes